Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of antigens for Ebola viruses.

FDA Recall Z-2403-2016 · Posted 2016-08-17

Recall StatusTerminated
Date Initiated2016-07-20
Date Terminated2017-05-10
Product Quantity3,075 units

Reason for Recall

Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions.

Firm Action

OraSure contacted the sole customer via email and mail (letter dated July 21, 2016) to request return of all the product from the affected lot.

Root Cause

Process control

Distribution Pattern

Distributed to one customer only in US state of Georgia.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑